1-8 of 8
Atto Billio, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prolonged Survival Of Poor Risk Follicular Lymphoma Patients Following Primary Treatment With Rituximab-Supplemented CHOP Or HDS With Autograft: Long-Term Results Of The Multicenter Randomized GITMO/FIL Trial

Corrado Tarella, MD, Fabio Benedetti, MD, Carola Boccomini, MD, Caterina Patti, MD, Anna Maria Barbui, MD, Alessandro Pulsoni, MD, Maurizio Musso, Anna Marina Liberati, Guido Gini, MD, Claudia Castellino, Fausto Rossini, Fabio Ciceri, M.D., Delia Rota Scalabrini, MD, Caterina Stelitano, Francesco Di Raimondo, MD, Tommasina Perrone, Alessandra Tucci, Atto Billio, MD, Francesco Zallio, MD, Valerio Zoli, MD, Angela Congiu, Franco Narni, MD, Alessandra Dondi, Guido Parvis, MD, Gianpietro Semenzato, MD, Paolo Corradini, Riccardo Bruna, MD, Angela Gueli, MD, Barbara Mantoan, Roberto Passera, Michele Magni, MD, Marco Ladetto
Journal: Blood
Blood (2013) 122 (21): 551.
https://doi.org/10.1182/blood.V122.21.551.551
Published: 2013
Journal Articles

Chemoimmunotherapy with R-CHOP or High Dose Sequential Therapy with Autologous Stem Cell Transplantation (R-HDS) for High Risk Diffuse Large B-Cell Lymphomas Patients: Results of the Randomized R-HDS0305 Trial by Gruppo Italiano Terapie Innovative Nei Linfomi (GITIL)

Sergio Cortelazzo, MD, Corrado Tarella, MD, Alessandro Massimo Gianni, MD, Tiziano Barbui, MD, Marco Ladetto, MD, Anna Maria Barbui, MD, Andrea Rossi, MD, Paolo Corradini, MD, Massimo Di Nicola, MD, Caterina Patti, MD, Antonino Mulé, MD, Manuela Zanni, MD, Valerio Zoli, MD, Atto Billio, MD, Andrea Gallamini, MD, Francesco Di Raimondo, MD, Andrés J.M. Ferreri, MD, Giovanni Pizzolo, MD, Giorgio La Nasa, MD, Pietro Leoni, MD, Giampietro Semenzato, MD, Maurizio Frezzato, MD, Leonardo Flenghi, MD, Marco Scarano, Sc.D., Arianna Masciulli, BSc, Roberto Marchioli, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2012) 120 (21): 746.
https://doi.org/10.1182/blood.V120.21.746.746
Published: 2012
Journal Articles

High Response Rate with Favorable Survival Projections in High-Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Receiving R-CHOP-14 or Early Intensified Chemotherapy with Rituximab and Autograft (R-HDS): Results of the Interim Analysis of A GITIL Prospective Multicenter Phase III Study.

Sergio Cortelazzo, MD, Corrado Tarella, MD, Alessandro M. Gianni, MD, Marco Ladetto, MD, Manuela Zanni, MD, Paolo Corradini, MD, Massimo Di Nicola, MD, Caterina Patti, MD, Antonino Mulè, MD, Ignazio Majolino, MD, Atto Billio, MD, Angela Gueli, MD, Francesco Di Raimondo, MD, Annalisa Chiarenza, MD, Andrea Gallamini, MD, Andres Ferreri, MD, Giovanni Pizzolo, MD, Fabio Benedetti, MD, Giorgio La Nasa, MD, Pietro Leoni, MD, Guido Gini, MD, Livio Trentin, MD, Francesco Rodeghiero, MD, Roberto Marchioli, MD, Tiziano Barbui, MD, Anna Barbui, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2009) 114 (22): 1220.
https://doi.org/10.1182/blood.V114.22.1220.1220
Published: 2009
Journal Articles

Expression of the Human Concentrative Nucleotide Transporter (hCNT1) Gene Correlates with Clinical Response in Patients Affected by Waldenstrom’s Macroglobulinemia (WM), Undergoing a Combination Treatment with Cladribine (2-CdA) and Rituximab.

Daniele Laszlo, MD, Cristina Rabascio, DSc, Giovanna Andreola, MD, Luca Saronni, DSc, Liliana Calabrese, DSc, Luigi Rigacci, MD, Alberto Fabbri, MD, Antonello Pinto, MD, Ferdinando Frigeri, MD, Atto Billio, MD, Graziella Pinotti, MD, Simona Sammassimo, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2007) 110 (11): 1357.
https://doi.org/10.1182/blood.V110.11.1357.1357
Published: 2007
Journal Articles

Update of a GITIL Cohort Study: Frontline High Dose Sequential Chemotherapy with Rituximab and Autologous Stem Cell Transplantation Induces a High Rate of Long-Term Remissions in Patients with Mantle Cell Lymphoma

Sergio Cortelazzo, MD, Michele Magni, MD, Corrado Tarella, MD, Michael Mian, MD, Atto Billio, MD, Andrea Rossi, MD, Maddalena Marchesi, MD, Andrea Gallamini, MD, Paolo Corradini, MD, Fabio Ciceri, MD, Guido Parvis, MD, Ignazio Majolino, MD, Caterina Patti, MD, Salvo Mirto, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Alessandro M. Gianni, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2007) 110 (11): 1282.
https://doi.org/10.1182/blood.V110.11.1282.1282
Published: 2007
Journal Articles

A GITIL Prospective Randomized Multicenter Phase III Study of High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Transplantation (ASCT) of Peripheral Blood Stem Cells Versus CHOP and Rituximab Delivered Every 14 Days (R-CHOP-14) in High-Risk Patients with Diffuse Large B-Cell Lymphomas (DLBCL): Interim Analysis on Feasibility and Toxicity (Protocol R-HDS 0305).

Sergio Cortelazzo, MD, Atto Billio, MD, Alessandro Rambaldi, MD, Corrado Tarella, MD, Ingnazio Majolino, MD, Alessandro M. Gianni, MD, Paolo Corradini, MD, Catterina Patti, MD, Salvo Mirto, MD, Giovanna Borrelli, PhD, Roberto Marchioli9, MD
Journal: Blood
Blood (2007) 110 (11): 1898.
https://doi.org/10.1182/blood.V110.11.1898.1898
Published: 2007
Journal Articles

Frontline High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Stem Cell Transplantation Induces High Rates of Complete Response and Prolongs Survival in Mantle Cell Lymphoma (MCL).

Sergio Cortelazzo, MD, Michele Magni, MD, Milena Pintimalli, MD, Michael Mian, MD, Andrea Rossi, MD, Atto Billio, MD, Maddalena Marchesi, MD, Manuela Zanni, MD, Corrado Tarella, MD, Mario Boccadoro, MD, Angelo Andreini, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Tiziano Barbui, MD, Alessandro M. Gianni, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2006) 108 (11): 3045.
https://doi.org/10.1182/blood.V108.11.3045.3045
Published: 2006
Journal Articles

Favorable Influence of Rituximab with High Dose Sequential Chemotherapy (R-HDS) Programs and Autologous Stem Cell Transplantation (ASCT) in Salvage Treatment for Patients with Refractory or Relapsed B-Cell Non-Hodgkin’s Lymphoma.

Milena Pintimalli, MD, Michael Mian, MD, Andrea Rossi, MD, Marco Sorio, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Atto Billio, MD, Tiziano Barbui, MD, Alessandro Rambaldi, MD, Sergio Cortelazzo, MD
Journal: Blood
Blood (2006) 108 (11): 2744.
https://doi.org/10.1182/blood.V108.11.2744.2744
Published: 2006